Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Departamento de Medicina, Disciplina de Nefrología, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Biol Res. 2024 Nov 7;57(1):81. doi: 10.1186/s40659-024-00560-8.
During diabetes, prorenin is highly produced by the renal collecting ducts. The binding of prorenin to (pro)renin receptor (PRR) on the apical plasma membrane triggers intracellular profibrotic genes, including TGF-β and CTGF. However, the underlying mechanisms contributing to the stimulation of these pathways remain unclear. Hence, we hypothesize that the glucose transporter-1 (GLUT1) favors the PRR-dependent stimulation of TGF-β and CTGF in the distal nephron segments during high glucose (HG) conditions.
To test this hypothesis, primary cultured renal inner medullary collecting duct (IMCD) cells were treated with normal glucose (NG, 5 mM) or high glucose (HG, 25 mM) for 48 h in the presence or absence of the GLUT1-specific inhibitor BAY 876 (2 nM). Additionally, IMCD cells were treated with the PRR antagonist PRO20. The expression of TGF-β and CTGF was quantified by immunoblot and qRT-PCR.
HG increased GLUT1 mRNA and protein abundance, while BAY 876 inhibited these responses. HG treatment upregulated PRR, but the concomitant treatment with BAY 876 partially prevented this effect. TGF-β and CTGF expressions were augmented in IMCD cells treated with HG. However, PRO20 prevented the increases in TGF-β but not those of CTGF. GLUT1 inhibition partially prevented the increases in reactive oxygen species (ROS) during HG while PRO20 did not. ROS scavenging impaired CTGF upregulation during HG conditions. Additionally, long-term exposure to HG increases lipid peroxidation and reduced cell viability.
The data indicate that glucose transportation via GLUT1 is implicated in the PRR-dependent upregulation of TGF-β while CTGF is mediated mainly via a mechanism depending on ROS formation in renal medullary collecting duct cells.
在糖尿病中,肾集合管高度产生前胰蛋白酶。前胰蛋白酶与顶端质膜上的(前)肾素受体(PRR)结合,触发包括 TGF-β 和 CTGF 在内的细胞内纤维原性基因。然而,导致这些途径刺激的潜在机制仍不清楚。因此,我们假设在高葡萄糖(HG)条件下,葡萄糖转运蛋白-1(GLUT1)有利于 PRR 依赖性刺激远曲小管段的 TGF-β 和 CTGF。
为了验证这一假设,用正常葡萄糖(NG,5mM)或高葡萄糖(HG,25mM)处理原代培养的肾髓质集合管(IMCD)细胞 48 小时,在存在或不存在 GLUT1 特异性抑制剂 BAY 876(2nM)的情况下。此外,还使用 PRR 拮抗剂 PRO20 处理 IMCD 细胞。通过免疫印迹和 qRT-PCR 定量 TGF-β 和 CTGF 的表达。
HG 增加 GLUT1 mRNA 和蛋白丰度,而 BAY 876 抑制了这些反应。HG 处理上调了 PRR,但同时用 BAY 876 处理部分阻止了这种作用。HG 处理的 IMCD 细胞中 TGF-β 和 CTGF 的表达增加。然而,PRO20 阻止了 TGF-β的增加,但没有阻止 CTGF 的增加。GLUT1 抑制在 HG 期间部分阻止了活性氧(ROS)的增加,而 PRO20 则没有。ROS 清除剂削弱了 HG 条件下 CTGF 的上调。此外,长期暴露于 HG 会增加脂质过氧化作用并降低细胞活力。
数据表明,GLUT1 介导的葡萄糖转运与 PRR 依赖性 TGF-β 的上调有关,而 CTGF 主要通过依赖于肾髓质集合管细胞 ROS 形成的机制来介导。